Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 7/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.41 |
| ▸ | BAX | Q07812 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | AR | P10275 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29586985 | 1.00 | LTA4H (0.45) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL9556964 | 0.84 | LTA4H (0.52) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL20591216 | 0.83 | MEN1 (0.55) | LTA4HMEN1KMT2APOLBMMP2 | |
| SCHEMBL2876479 | 0.82 | L3MBTL1 (0.50) | TSHRARFFAR1MAPTL3MBTL1 | |
| SCHEMBL29580858 | 0.82 | L3MBTL1 (0.50) | TSHRARFFAR1MAPTL3MBTL1 | |
| SCHEMBL12871225 | 0.80 | LTA4H (0.63) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL6357397 | 0.80 | LTA4H (0.63) | LTA4HTSHRNR1H2BAXMAOA | |
| SCHEMBL20955831 | 0.79 | LTA4H (0.52) | LTA4HTSHRARMEN1KMT2A | |
| SCHEMBL29587704 | 0.79 | LTA4H (0.52) | LTA4HTSHRARMEN1KMT2A | |
| SCHEMBL15418919 | 0.79 | AR (0.43) | TSHRARFFAR1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3480205-B1 | SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF | SAN APRO LTD (JP) | 2022-04-13 | — | — | EP | disclosed |
| CN-108884110-B | Sulfonium salt, photoacid generator, photocurable composition, and cured product thereof | 三亚普罗股份有限公司 | 2021-09-14 | — | — | CN | disclosed |
| US-10683266-B2 | Sulfonium salt, photoacid generator, photocurable composition, and cured product thereof | SAN APRO LTD. (JP) | 2020-06-16 | — | — | US | disclosed |
| US-20190300476-A1 | SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF | SAN-APRO LTD. (JP) | 2019-10-03 | — | — | US | disclosed |
| EP-3480205-A1 | SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF | San-Apro Ltd. (JP) | 2019-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190300476-A1 | SULFONIUM SALT, PHOTOACID GENERATOR, PHOTOCURABLE COMPOSITION, AND CURED PRODUCT THEREOF | ASIC1, TST, SPIN2B | LTA4H 1255/4885TSHR 2727/4885NR1H2 4347/4885 |
| US-10683266-B2 | Sulfonium salt, photoacid generator, photocurable composition, and cured product thereof | ASIC1, TST, SPIN2B | LTA4H 1255/4885TSHR 2727/4885NR1H2 4347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.